Search - tctmd.com

Displaying 1 - 20 of 100

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Presenter: Antonin Trimaille

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

Presenter: Tobias Geisler

October 28, 2024

Presentation TCT 2024

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

Presenter: Jae Hyun Jae

October 28, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 396: Calcification Patterns in TAVR Explants: Informing Durability & Implications for Reintervention

Presenter: Stephanie Sellers

October 25, 2023

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Advertisement

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

What’s Going to Be Hot at TCT 2025

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Lessons Learned From the SMART Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCT 396: Calcification Patterns in TAVR Explants: Informing Durability & Implications for Reintervention

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Valve Fracture for ViV TAVI Linked With Higher Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content